Collectively, these observations suggest that EPAS1 reduction in obesity may result from hypertriglyceridemia-FFA metabolism coupled to localized alterations in cellular oxidative stress leading to the induction of endothelial PHD2. This evidence concerns the gene EGLN1 and obesity disorder.